Diabetic ketoacidosis and clozapine

Postgraduate Medical Journal

Volumn 74, Issue 874, 1998, Pages 493-494

  Ai, Dawn ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adverse drug reaction; Afro Caribbeans; Clozapine; Diabetes; Keroacidosis

Indexed keywords

CLOZAPINE; GLICLAZIDE; INSULIN; NEUROLEPTIC AGENT; OLANZAPINE; POTASSIUM;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA;

EID: 0031660519     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.74.874.493     Document Type: Article

References (3)

1. Anon. Update of clozapine. Med Lett Drugs Ther 1993;35:16-8.
2. Yakeley JW, Murray RM. Schizophrenia. Med Int Psychiatry 1996;24:2.
3. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J O'Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996;169:483-8.